Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
31 hedge funds and large institutions have $64.4M invested in Global Cord Blood Corporation in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 8 closing their positions.
63% more capital invested
Capital invested by funds: $39.6M → $64.4M (+$24.8M)
3% less funds holding
Funds holding: 32 → 31 (-1)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
20% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 10
76% less call options, than puts
Call options by funds: $149K | Put options by funds: $627K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$15.5M |
| 2 |
Man Group
London,
United Kingdom
|
+$1.98M |
| 3 |
OMC
Oasis Management Company
Grand Cayman,
Cayman Islands
|
+$1.89M |
| 4 |
Barclays
London,
United Kingdom
|
+$455K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$445K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$1.09M |
| 2 |
Morgan Stanley
New York
|
-$900K |
| 3 |
SG Americas Securities
New York
|
-$393K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$314K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$126K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Morgan Stanley
New York
| $13K | -$900K | -171,950 | -99% |
|
|
CWC
27
Carolinas Wealth Consulting
Charlotte,
North Carolina
| $9K | +$8.37K | +1,600 | New |
|
|
GLLW
28
Graves Light Lenhart Wealth
Harrisonburg,
Virginia
| $3K | +$3.14K | +600 | New |
|
29
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | -$1.01K | -193 | -28% |
|
|
SPIA
30
Steward Partners Investment Advisory
New York
| $2K | – | – | – |
|
|
CCIA
31
Campbell & Co Investment Adviser
Baltimore,
Maryland
| – | -$124K | -27,400 | Closed |
|
|
SSA
32
Schonfeld Strategic Advisors
New York
| – | -$124K | -27,400 | Closed |
|
33
JP Morgan Chase
New York
| – | -$87K | -19,114 | Closed |
|
34
Northern Trust
Chicago,
Illinois
| – | -$52K | -11,359 | Closed |
|
|
MGIA
35
Moneta Group Investment Advisors
St Louis,
Missouri
| – | -$50K | -11,038 | Closed |
|
|
VFA
36
Valeo Financial Advisors
Carmel,
Indiana
| – | -$19K | -4,110 | Closed |
|
37
BlackRock
New York
| – | -$11K | -2,416 | Closed |
|
38
UBS Group
Zurich,
Switzerland
| – | -$2K | -419 | Closed |
|
CO Hedge Fund Activity: Q2 2021 in Review
31 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q2 2021, worth a combined $64.4M — up 63% from $39.6M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of CO and 7 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 8 added.
The largest buyer was BlueCrest Capital Management, adding an estimated $15.5M. The largest seller was Renaissance Technologies, cutting an estimated $1.09M.
- 31 institutional investors held Global Cord Blood Corporation (CO) as of Q2 2021, down from 32 in Q1 2021.
- Funds reported $64.4M of Global Cord Blood Corporation stock for Q2 2021, up 63% quarter-over-quarter.
- 7 funds opened new Global Cord Blood Corporation positions in Q2 2021 and 8 closed out, a net change of -1 holder.
- The largest Global Cord Blood Corporation buyer in Q2 2021 was BlueCrest Capital Management, an estimated $15.5M added.
- The largest Global Cord Blood Corporation seller in Q2 2021 was Renaissance Technologies, an estimated $1.09M sold.
Based on aggregated 13F filings for Q2 2021.